RIG
37
-9
DHR
62
-2
QCOM
40
-17
WYNN
48
-7
ADP
66
4
RF
63
-14
WM
57
-22
EFX
50
-2
LH
43
-5
TGT
57
-14
CVS
33
-2
SCHW
56
-19
FTI
63
3
ES
47
-3
HAL
50
3
UA
15
-32
VFC
70
-2
SWK
52
-10
UAL
72
-13
UPS
40
-18
RIG
37
-9
DHR
62
-2
QCOM
40
-17
WYNN
48
-7
ADP
66
4
RF
63
-14
WM
57
-22
EFX
50
-2
LH
43
-5
TGT
57
-14
CVS
33
-2
SCHW
56
-19
FTI
63
3
ES
47
-3
HAL
50
3
UA
15
-32
VFC
70
-2
SWK
52
-10
UAL
72
-13
UPS
40
-18
Financhill
Back

4D Molecular Therapeutics, Inc. Vs. Zenas BioPharma, Inc. Industry Stock Comparison

Sell
37

FDMT
4D Molecular Therapeutics, Inc.

Last Price:
$8.70
Seasonality Move:
-3.73%
Sell
29

ZBIO
Zenas BioPharma, Inc.

Last Price:
$35.01
Seasonality Move:
0.59%
Sell
37
4D Molecular Therapeutics, Inc. (FDMT) is a Sell

Is 4D Molecular Therapeutics, Inc. a Buy, Sell or Hold?

  • The current 4D Molecular Therapeutics, Inc. [FDMT] share price is $9.21. The Score for FDMT is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • FDMT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
29
Zenas BioPharma, Inc. (ZBIO) is a Sell

Is Zenas BioPharma, Inc. a Buy, Sell or Hold?

  • The current Zenas BioPharma, Inc. [ZBIO] share price is $35.81. The Score for ZBIO is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • ZBIO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FDMT Stock Price Chart

What is 4D Molecular Therapeutics, Inc.'s stock price today?

  • The 4D Molecular Therapeutics, Inc. share price today is $9.21
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FDMT is experiencing selling pressure, which indicates risk of future bearish movement.

ZBIO Stock Price Chart

What is Zenas BioPharma, Inc.'s stock price today?

  • The Zenas BioPharma, Inc. share price today is $35.81
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ZBIO is experiencing slight selling pressure.

FDMT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.01 Buy
Relative Strength Index (14 RSI): 39.79 Sell
Chaikin Money Flow: -2871004 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.25 - 11.21) Sell
Bollinger Bands (100): (6.65 - 10.87) Buy

ZBIO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.86 Buy
Relative Strength Index (14 RSI): 49.55 Sell
Chaikin Money Flow: -89322 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (35.22 - 39.36) Sell
Bollinger Bands (100): (17.16 - 33.88) Buy

FDMT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 10.73 Sell
20-day SMA: 10.76 Sell
50-day SMA: 10.67 Sell
200-day SMA: 6.25 Buy
8-day EMA: 10.6 Sell
20-day EMA: 10.7 Sell
50-day EMA: 10.21 Sell
200-day EMA: 8.24 Buy

ZBIO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 37.84 Sell
20-day SMA: 37.69 Sell
50-day SMA: 32.84 Buy
200-day SMA: 17.75 Buy
8-day EMA: 7.96 Buy
20-day EMA: 3.41 Buy
50-day EMA: 1.4 Buy
200-day EMA: 0.36 Buy

4D Molecular Therapeutics, Inc. Earnings Growth & FDMT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.33 per share, and a decrease next year of $0.22 per share.

Zenas BioPharma, Inc. Earnings Growth & ZBIO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.65 per share, and an increase next year of $0.59 per share.

4D Molecular Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Zenas BioPharma, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):